EA200801306A1 - SULFAMOULSULPHONATE PRECAUTIONS - Google Patents

SULFAMOULSULPHONATE PRECAUTIONS

Info

Publication number
EA200801306A1
EA200801306A1 EA200801306A EA200801306A EA200801306A1 EA 200801306 A1 EA200801306 A1 EA 200801306A1 EA 200801306 A EA200801306 A EA 200801306A EA 200801306 A EA200801306 A EA 200801306A EA 200801306 A1 EA200801306 A1 EA 200801306A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sulfamoulsulphonate
precautions
general formula
relates
sulfonate prodrugs
Prior art date
Application number
EA200801306A
Other languages
Russian (ru)
Inventor
Ральф Вырва
Райнхардт Нуббемейер
Урсула Ганцер
Original Assignee
Байер Шеринг Фарма Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Шеринг Фарма Акциенгезельшафт filed Critical Байер Шеринг Фарма Акциенгезельшафт
Publication of EA200801306A1 publication Critical patent/EA200801306A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group

Abstract

Изобретение относится к сульфамоилсульфонатным пролекарствам общей формулы IThe invention relates to sulfamoyl sulfonate prodrugs of General formula I

EA200801306A 2005-11-30 2006-11-27 SULFAMOULSULPHONATE PRECAUTIONS EA200801306A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005057408A DE102005057408A1 (en) 2005-11-30 2005-11-30 New sulfamoylsulfonate prodrugs e.g. useful for protecting red blood cells from attack by parasites or for hormone replacement therapy, female fertility control or treating hormone-associated diseases
PCT/EP2006/011726 WO2007062874A2 (en) 2005-11-30 2006-11-27 Sulfamoyl sulfonate prodrugs

Publications (1)

Publication Number Publication Date
EA200801306A1 true EA200801306A1 (en) 2008-10-30

Family

ID=37983623

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801306A EA200801306A1 (en) 2005-11-30 2006-11-27 SULFAMOULSULPHONATE PRECAUTIONS

Country Status (15)

Country Link
EP (1) EP1957513A2 (en)
JP (1) JP2009517424A (en)
KR (1) KR20080072956A (en)
CN (1) CN101316858A (en)
AU (1) AU2006319380A1 (en)
BR (1) BRPI0619253A2 (en)
CA (1) CA2632272A1 (en)
CR (1) CR10003A (en)
DE (1) DE102005057408A1 (en)
EA (1) EA200801306A1 (en)
EC (1) ECSP088489A (en)
IL (1) IL191570A0 (en)
NO (1) NO20082915L (en)
WO (1) WO2007062874A2 (en)
ZA (1) ZA200805659B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010110747A1 (en) * 2009-03-24 2010-09-30 National University Of Singapore Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (copd)
CN101987101A (en) * 2009-08-05 2011-03-23 天津金耀集团有限公司 Anti-inflammatory eye composition with glucocorticoid aromatic sulfamoyl sulfonic acid ester as active ingredient
CN101987104A (en) * 2009-08-05 2011-03-23 天津金耀集团有限公司 Ophthalmic composition of heteroaryl sulfamoyl carboxylic ester carbonic anhydrase inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (en) * 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
DE102004025966A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estradiol prodrugs
DE102004025985A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estriol and estetrol prodrugs
DE102004025986A1 (en) * 2004-05-21 2005-12-15 Schering Ag Steroid prodrugs with androgenic effects

Also Published As

Publication number Publication date
EP1957513A2 (en) 2008-08-20
AU2006319380A1 (en) 2007-06-07
WO2007062874A3 (en) 2007-07-12
CN101316858A (en) 2008-12-03
IL191570A0 (en) 2008-12-29
WO2007062874B1 (en) 2007-09-27
DE102005057408A1 (en) 2007-05-31
BRPI0619253A2 (en) 2011-09-27
CA2632272A1 (en) 2007-06-07
KR20080072956A (en) 2008-08-07
NO20082915L (en) 2008-06-27
WO2007062874A2 (en) 2007-06-07
JP2009517424A (en) 2009-04-30
ZA200805659B (en) 2009-10-28
CR10003A (en) 2008-08-21
ECSP088489A (en) 2008-06-30

Similar Documents

Publication Publication Date Title
CR10662A (en) METHYLPIRIDOPIRIMIDINONE COMPOUNDS
CY1112467T1 (en) 1-SULF-D-GLYCITOLIS PRODUCT
CY1110489T1 (en) ISKINOLIN PRODUCTS
ATE483000T1 (en) NAPHTALINE-AMIDINE-IMIDE
CR9331A (en) VEGF-R2 INHIBITORS AND METHODS
CY1112102T1 (en) Substituted Pyramidodiazepine Uses As Suspensions PLK1
UY29612A1 (en) CHEMICAL COMPOUNDS II
EA200801608A1 (en) DERIVATIVES OF BENZIMIDAZOLONIC CARBONIC ACID
EA200900945A1 (en) NEW METHOD OF SYNTHESIS AGOMELATIN
CR11241A (en) PIRAZOL COMPOUNDS AND ITS USE AS RAF INHIBITORS
CR20120421A (en) AMINOHETETOARILO COMPOUNDS OR SUBSTITUTED WITH PIRAZOL AS PROTEIN QUINASA INHIBITORS
ATE400567T1 (en) KINASE INHIBITORS
SV2010003502A (en) NEW FUNGICIDES
ATE554066T1 (en) ANTI-INFLAMMATORY SUBSTITUTED CYCLOBUTENDIONE COMPOUNDS
BRPI0520870B8 (en) intermediate compounds for the preparation of s-triazolyl alpha-mercaptoacetanilides
EA200702464A1 (en) METHODS OF OBTAINING PHENOL 4-BIPHENYLILAZETIDIN-2-ONES
EA200900946A1 (en) NEW METHOD OF SYNTHESIS AGOMELATIN
EA200801365A1 (en) SUBSTITUTED 5-PHENYL-3,6-DIGIDRO-2-OXO-6H-1,3,4-TIADIAZINS
EA200801145A1 (en) SPYROCYCLIC DERIVATIVES OF HINAZOLIN AS PDE7 INHIBITORS
CY1111978T1 (en) CONSUMPTION OF MACROLIDES WITH ANTI-INFLAMMATORY ACTION
EA200801366A1 (en) DERIVATIVES 3,6-DIGIDRO-2-OXO-6N-1,3,4-TIADIAZINA
PA8792101A1 (en) NEW SYNTHESIS PROCEDURE OF (7-METOXI-1- NAFTIL) ACETO
EA201101675A1 (en) SPYROEPOXIDES AS INTERMEDIATE PRODUCTS OF SYNTHESIS
CR11463A (en) PIRIDILMETIL-SULFONAMIDE COMPOUNDS
ATE417849T1 (en) PYRAZOLOA4,3-DÜPYRIMIDINE